MT‑TL2 Mitochondrial Encephalomyopathy Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM–11 PM, daily).
Clinical Guidance: Post‑test telephonic interpretation by a licensed genetic counsellor.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This advanced Next‑Generation Sequencing (NGS) test analyses the mitochondrial MT‑TL2 gene for pathogenic variants linked to encephalomyopathy syndromes such as MELAS, MERRF, and overlapping mitochondrial cytopathies. Full gene sequencing combined with confirmatory Sanger chemistry provides definitive molecular diagnosis.

Feature	Our Test (Premium Panel)	Standard mtDNA Hotspot Test
Precision	Full gene sequencing (all exons, flanking regions)	Limited to 10–15 common point mutations
Methodology	NGS (Illumina platform) with confirmatory Sanger	PCR‑RFLP or targeted genotyping
Turnaround Time	3 to 4 Weeks (ISO cold‑chain logistics)	2–3 Weeks (fewer quality checks)

Physician Insight & Safety Protocols

“MT‑TL2 sequencing offers definitive molecular confirmation for mitochondrial encephalomyopathy, dramatically shortening the diagnostic journey. However, a negative result does not exclude mitochondrial disease; clinical correlation and tissue‑specific heteroplasmy testing remain essential. Always interpret these findings alongside a thorough neurological examination and metabolic work‑up.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)

Pre‑Test Advisory

⚠ Important Pre‑Test Information

Do not discontinue any prescribed medication (especially antiepileptics, coenzyme Q10, or mitochondrial cocktails) without consulting your physician. Abrupt withdrawal may trigger severe metabolic decompensation.

Exclusion Criteria & Emergency Red Flags

Safety Box – When to Avoid Home Collection & Seek Immediate Care

Exclusion Criteria for Home Collection: Haemodynamic instability, acute infection with fever >38.5°C, recent (within 72 h) convulsive seizure, or child below age of consent without legal guardian present.
ER Red Flags – Seek Immediate Emergency Care: Stroke‑like episodes, new‑onset status epilepticus, acute encephalopathy with lactic acidosis, or sudden visual field deficits.

Patient FAQ & Clinical Guidance

1. What does a positive MT‑TL2 variant result mean for my diagnosis?

A positive result identifies a pathogenic or likely pathogenic mutation in the MT‑TL2 gene, confirming a mitochondrial genetic aetiology for your encephalomyopathy and enabling precise genetic counselling and family risk assessment.

2. How is this test different from a standard mitochondrial DNA panel?

Unlike limited hotspot panels, our NGS sequences the entire MT‑TL2 gene with deep coverage, detecting rare variants, heteroplasmy levels, and large deletions that conventional methods miss.

3. Can I use this result for family planning and prenatal testing?

Yes, once a familial MT‑TL2 variant is identified, targeted testing for maternal heteroplasmy and mitochondrial donation/transfer options can be discussed with a genetic counsellor, strictly adhering to UAE guidelines on reproductive genetics.

UAE Regulatory & Data Privacy Adherence

Data Protection: Your genetic data is handled in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Clinical Safety: Patient consent and clinical responsibility adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Accreditations: ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139 | DHA Licensed Facility No: 1143

Clinical & Logistical Metadata

Test Name	MT‑TL2 Mitochondrial Encephalomyopathy Genetic Test (Full Gene NGS)
Price (AED)	2,800 AED
Turnaround Time	3 to 4 Weeks
Sample Type / Matrix	Peripheral whole blood (EDTA) – VIP Mobile Phlebotomy & Cold‑Chain Home Collection available daily 8 AM–11 PM
Methodology Used	Next‑Generation Sequencing (Illumina) + Confirmatory Sanger Sequencing
ICD‑10‑CM Code	G71.3 (Mitochondrial myopathy, not elsewhere classified)
LOINC Code	80293‑0 (Mitochondrial DNA gene analysis)
DHA Facility License & Address	DHA License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE